A common cause of pathological nystagmus is malfunction of the mechanism by which the brain integrates eye velocity signals to produce eye position commands. For horizontal gaze, neurons in the nucleus prepositus hypoglossi-medial vestibular nucleus region (NPH-MVN) play a vital role in this neural integrator function. We studied the effects on gaze stability of pharmacological intervention in the NPH-MVN of monkeys by microinjections of eight drugs. Agents with agonist or antagonist actions at gamma-aminobutyric acid (GABA), glutamate, and kainate receptors all caused gaze-evoked nystagmus with centripetal eye drifts; glycine and strychnine had no effect. When the GABA A -agonist muscimol was injected near the center of MVN, the eyes drifted away from the central position with increasing-velocity waveforms, implying an unstable neural integrator. The observed effects of these drugs on gaze stability may be related to inactivation either of neurons within NPH-MVN or the cerebellar projections to them that control the fidelity of neural integration. Drugs that influence GABA or glutamine transmission may have a role in the treatment of nystagmus due to an abnormal neural integrator. Published by Elsevier Science Ltd.
Introduction
For a clear and stable view of the world, images must be held steadily on the retina, and the fovea must be pointed at the object of interest (Carpenter, 1991) . In order to view clearly an object located off to one side, each eye must be held at an eccentric position in the orbit. The latter requires a tonic contraction of the extraocular muscles to oppose the elastic forces imposed by the orbital tissues, which act to return the eye to a central position (Leigh & Zee, 1999) . To achieve this sustained muscle contraction, the ocular motoneurons must encode commands that have an eye position component to them. Electrophysiological studies confirm that the ocular motoneurons do modulate their discharge rate with eye position -and also with velocity during movements (Fuchs, Scudder & Kaneko, 1988) . However, premotor neurons that send vestibular (Waespe & Henn, 1977) , saccadic (Van Gisbergen, Robinson & Gielen, 1981) , and pursuit signals (Miles & Fuller, 1975) to the ocular motoneurons modulate their discharge with eye velocity, not position. This difference implies that an integration of velocity-coded to position-coded signals is achieved by the nervous system (Robinson, 1975; Arnold & Robinson, 1997) . It is now established that, for horizontal eye movements, this neural integration depends heavily upon the nucleus prepositus hypoglossi-medial vestibular nucleus region (NPH-MVN) in the caudal pons and medulla (Cannon & Robinson, 1987; Cheron & Godaux, 1987) ; for vertical eye movements, the interstitial nucleus of Cajal plays a key role (Helmchen, Rambold, Fuhry & Bü ttner, 1998) . In addition, the cerebellum, especially the flocculus, makes an important contribution (Carpenter, 1972; Robinson, 1974; Zee, Yamazaki, Butler & Gü cer, 1981) . Thus, lesions of any of these structures impair the ability to hold the eyes in eccentric gaze; they drift back towards the center of the orbits, and corrective quick phases cause gaze-evoked nystagmus -perhaps the commonest form of pathological nystagmus (Leigh & Zee, 1999) .
Recently, attempts have been made to understand what neurotransmitters may be involved in the process of neural integration, using the technique of pharmacological inactivation. Such knowledge is directly relevant to understanding and treating pathological nystagmus which interferes with clear vision. In the cat, microinjection of the GABA A -agonist muscimol into NPH-MVN abolishes neural integration for horizontal movements, so that the centripetal drift of the eyes after a saccade is determined by the elastic pull of the orbit tissues (Mettens, Godaux, Cheron & Galiana, 1994a) . Similar results are reported after muscimol injections into the MVN of monkeys (Straube, Kurzan & Bü ttner, 1991) . However, other neurotransmitters are reported to contribute to normal function of the neural integrator (Mettens, Cheron & Godaux, 1994b) . One goal of the present study was to compare the effects of agonist and antagonist agents acting at GABA A , glutamate, kainate, and glycine receptors.
Methods

Preparation of animals
All animal experiments were conducted in strict accordance with principles of laboratory animal care (NIH publication No. 86-23, revised 1985) . Three juvenile rhesus monkeys, Macaca mulatta, weighing between 2.5 and 4 kg, were used in this study. Each monkey underwent two operations performed under pentobarbital anesthesia and aseptic conditions. In the first, a coil of wire was implanted in one eye, as previously described (Arnold & Robinson, 1997) , to measure eye movements. One week later the animal was trained to fixate dots back-projected on a screen by a laser under the control of an x -y mirror galvanometer. The monkeys were deprived of water for 1 day prior to each training session and during the session the monkey was given a liquid reward for correct fixation. After several sessions the monkey learned to fixate the light at various positions and the eye coil was calibrated. The second surgery involved trephining a hole 2 cm in diameter in the midline of the occipital area of the monkey's skull. A stainless steel recording chamber (Trent Wells 3-0558) was then implanted over the hole. Its axis lay in the midsagittal plane, tilted back from the vertical by 20°and was positioned so that it would pass through a point on the midline 4 mm posterior to and 2 mm above the inter-aural axis. This corresponds to a position midway between the abducens nuclei (Smith, Kastella & Randall, 1972 
Measurement of eye mo6ements, unit recording and stimulation
Eye movements were recorded using the eye-coil/ magnetic-field system (Robinson, 1963) . The monkey sat in a primate chair with its head fixed in the center of the field coils. The noise level of the system was approximately 15 min of arc, and bandwidth was 0-1 kHz. An ultra-violet mirror-galvanometer (Honeywell Visicorder 1108) and an FM tape recorder (Vetter Model B), simultaneously recorded horizontal and vertical movements of one eye, and target position, when relevant.
The goal of recording from single neurons was to locate the abducens nuclei and identify sites for injection. Monopolar tungsten micro-electrodes were used for single-unit extracellular recording and stimulation. The tips were insulated with epoxylite varnish until their impedance (at 1 kHz) was between 1 and 3 MV for recording electrodes and about 500 kV for stimulating electrodes. The electrode was placed in a guide tube consisting of 22 gauge tubing cut to a length between 68 and 72 mm depending on the size of the monkey's head. This assembly was then inserted into the brain so that the tip of the guide tube lay approximately 6 mm above the floor of the fourth ventricle. The electrode was then advanced out of the guide tube, through the cerebellum and fourth ventricle, and into the brainstem using a Trent Wells hydraulic microdrive (3-0590).
Recordings were made at various locations to allow a map of brainstem landmarks to be made. The two abducens nuclei were identified by the characteristic 'singing' sound produced on the audio monitor. In addition, the cells were very densely packed and all fired at a rate proportional to ipsilateral eye position and eye velocity. The rostro-caudal and medio-lateral borders of these areas were delineated to make sure that they were the abducens nuclei. A volume was then explored 1 mm to 2 mm caudal to the caudal border of the abducens nuclei and 1-4 mm lateral, where many sites were found in which firing rates of cells varied with eye movements, and stimulation produced eye movements. This was presumably the relevant region within the NPH-MVN and would especially include the marginal zone (McFarland & Fuchs, 1992) . Chemicals were injected throughout these regions.
Injections
Chemicals were injected into the NPH-MVN region via a 29 gauge metal cannula that was advanced through a guide tube in the same manner as the electrodes. Injections were made with a 10 ml Hamilton Luer tip microsyringe controlled by a stepper motor.
The volume of all injections was 1 ml; all were unilateral in each monkey. The chemicals were mixed in a solution of saline and Hepes buffer with a pH of 7.4. The following chemicals were used: muscimol (Sigma), 10 mM; bicuculline (Sigma), 10 mM; strychnine (Sigma), 100 mM; glycine (Sigma), 1 mM; kainic acid (Sigma), 50 mM; DNQX (6,7-Dinitroquinoxoline-2,3-dione) (Research Biochemicals), 10 mM; NMDA (Nmethyl-D-aspartic acid) (Sigma), 50 mM; APV (2-amino-5-phosphonovaleric acid) (Sigma), 1 mM. Before and at various times after the injections the monkey's random saccades, and post-saccadic drifts in the dark, were recorded to assess the function of the integrator. During these times the monkeys were kept alert by auditory stimulation. Generally, the monkey's integrator, if affected, recovered by 2 h, so that its time constant was at least 50% of the pre-injection value, when monitoring was stopped.
Lesions and identification of injection sites
Electrolytic midline lesions were made in two monkeys by passing 100 mA of anodic DC current into the brainstem for 1 min. Eye movement data were collected before and after the lesions. Each monkey was then allowed to recover for 4 -5 weeks at which point its spontaneous eye movements in the dark were recorded again to determine what recovery had taken place; these studies have been previously reported (Arnold & Robinson, 1997) . Shortly after the last recordings the monkeys were perfused under deep pentobarbital anesthesia with a cardiac injection of 10% neutral formalin through the left ventricle. The brains were blocked and 50 mm frozen sections were cut from them in a transverse plane containing the electrode tracks. Alternate sections were then stained with cresyl violet. These sections allowed localization of sites of injections and lesions.
Analysis of eye mo6ements
Eye movements were analyzed from the Visicorder output by hand. We analyzed gaze-holding in darkness after a saccade brought the eye to a new orbital position; smooth-pursuit and vestibular eye movements were not studied. The most common effect of the injections was to impair gaze holding so that the eyes drifted, with decreasing velocity, toward the center. In these cases, the time constant of the drift was measured to provide an estimate of neural integrator function. It is a property of an exponential of time constant~, that a tangent to it at a time t 0 will intersect the abscissa at time t 0 +~, thus providing a simple graphic way to estimate~. Since the variations in~created by these experiments covered two decades (0.2-20 s) an attempt at greater accuracy in measuring t would not have contributed to any better interpretation. Consequently, time constants were calculated by drawing a line tangent to the eye movement trace at a point immediately after a saccade and taking the difference between that time and the time at which the tangent line crossed the null position. The null position was measured, in each case, as the position (usually near zero) at which the postsaccadic eye velocity reversed its sign. Each time constant was calculated at five different points on a given recording and the average was used as the nominal value; the standard deviation reflected variability. Injections at some sites caused constant-velocity slow phases of nystagmus; in these cases, the velocity when the nystagmus was most intense, V max , was measured at five different points and averaged. Sometimes, injections caused increasingvelocity drifts (reflecting an unstable integrator); in these cases, negative time constants were measured in the same manner as positive time constants, except that the tangent line intercepted the null position in the negative direction on the time axis.
Results
Location of injections
Injections were made at points between 1 and 2 mm caudal to the abducens nuclei and 1 and 4 mm lateral to the midline. The positions of injections were determined by stereotaxic extrapolation from the physiologically identified loci of the abducens nuclei and were corroborated by histology. Fig. 1 illustrates some of the injection sites for muscimol (A), bicuculline (B), and other chemicals (C). This figure in conjunction with the coordinates given in Table 1 , permits the approximate location of all injection sites. With 41 injections in three monkeys, many overlapping, all cannula tracks could not be identified individually, although all were confined to the region illustrated. Moreover, 1 ml injections will probably spread over an effective distance of at least 90.5 mm. Although differences were seen between different injection sites (see below), the techniques used here were not intended to elucidate micocircuitry but only to test more general pharmacological localization of the neural integrator.
No overt non-oculomotor effects were noticed, except in the three muscimol injections that made the integrator unstable with negative time constants (indicated by asterisk in Table 1 ). In each of these cases the monkey put the ear ipsilateral to the injection side down on the floor of its cage for about 1 h following the end of the experiment.
Muscimol (GABA agonist) injections
Ten unilateral, 1 ml injections of 10 mM muscimol were made in the caudal pons, 1 -2 mm caudal to the abducens nuclei and 1 -3 mm lateral to the midline (Table 1) . Five of these injections, between 1 and 2.5 mm lateral, resulted in a marked reduction in the time constant of the integrator to the minimum value~m in shown. A typical example of such injections causing the integrator to become leaky is shown in Fig. 2 . Prior to injection ( Fig. 2A) , the monkey could hold eccentric gaze steadily in darkness. The normal time constant of centripetal eye drift for humans is approximately 20 s (Leigh & Zee, 1999) , and monkeys are comparable. The mild downbeat nystagmus in Fig. 2A is normal in the rhesus monkey. After the injection (Fig. 2B) , the integrator has become very leaky, causing gaze-evoked nystagmus. Note, however, that there was some variability in the centripetal drift, from beat to beat; that some individual slow phases appeared to show more than one rate of drift; and some were almost linear (see Section 4). After each of these five injections, the integrator time constant,~m in was reduced to between 0.2 and 1.5 s (mean 0.9 s) within 5 -10 min of the injection.
During a 2 h period following each injection, the time constant slowly increased to greater than 5 s. The time constant eventually returned to normal within a day or two. Fig. 3 illustrates typical time courses of the integrator time constants following these injections. The changes in time constants followed similar trajectories after each injection, and probably reflected the time course of the injection diffusing away from the site. Smaller time constants were associated with longer recovery periods. After an injection, the null point (estimated by noting the eye position at which post-saccadic drift reversed direction) shifted, even within 1 min, up to 10°either ipsilaterally or contralaterally, with no consistent trend. It tended to decrease toward zero, within an hour.
In two cases, injection of muscimol created simple nystagmus (V max , Table 1 ). The slow phases were straight indicating a normal integrator -otherwise they would have been curved. This is indicative of a vestibular imbalance similar to a peripheral vestibular lesion. Both sites were at the lateral limit (3 mm) investigated. The constant-velocity slow phases had a peak velocity of about 10°/s, ipsilateral to the injection.
Finally, injection at three sites (indicated by asterisks in Table 1 ) created a novel finding -they made the neural integrator unstable. As illustrated in Fig. 4A , the eyes drifted away from the null point with a waveform resembling a growing exponential, which can be described by a negative time constant. In each case the monkey only made eye movements on one side of the null point, the side ipsilateral to the injection.
The dependence of the results on the location of the injection is reported in Table 1 . Injections between 1.0 and 2.7 mm produced a reduction in integrator time constant. Injections around 2.7-3.0 mm made the integrator unstable (*) while more lateral injections at 3.0 mm produced nystagmus with linear slow phases. From  Fig. 1 , the boundary between the production of a leaky Fig. 1 . The location of the region of the injection sites. PH, nucleus prepositus hypoglossi; MVN, medial vestibular nucleus; DVN, descending vestibular nucleus; LVN, lateral vestibular nucleus; Y, y-group of the vestibular nucleus; SCP, superior cerebellar peduncle. The symbols represent examples of the loci where injections were made that resulted in the following effects: filled triangle, leaky integrator (see Fig. 2B for examples) ; star, unstable integrator (see Fig. 4A and B for examples); c , either an unstable integrator or constant-velocity nystagmus without affecting the integrator; filled circles, nystagmus without affecting the integrator (see Fig. 4C ), ×, no effect. All slices are through a transverse section plane tilted caudally from stereotactic vertical by 20°and 1.5 mm caudal to the abducens nuclei. (A) muscimol sites; (B) bicuculline sites; (C) sites where NMDA, APV, kainic acid, DNQX, glycine, strychnine, or saline were injected. For clarity, not all sites are shown; many sites overlapped; Table  1 provides the lateral location of every injection site. Fig. 4 . V max is the velocity of the slow phases of constant-velocity nystagmus, when it was most intense. In both cases following muscimol injection, the slow phases were ipsilateral. For the four cases following bicuculline injection, the slow phases of V max were ipsilateral in one case and contralateral in the other three. Recall from Fig. 1 that the locations less than 1.7 mm are probably in the NPH; from 1.7 to 3.5 in the MVN; and beyond 3.5 in the DVN. All injections were on the left (L) in Monkeys 1 and 3 and the right (R) in Monkey 2. Variability is shown by 91 S.D. All injections were 1 ml.
were made in roughly the same area of the caudal pons as the muscimol injections (Fig. 1B and Table 1 ). The three most medial injections, all between 1.0 and 1.5 mm and probably confined to the NPH, made the integrator leaky. The average time constant was 2.8 s. The time constants generally were reduced less and recovered faster than after muscimol injections (Fig. 3) . The null points stayed within 5°of the center of gaze and the direction of the shift was inconsistent. Four other injections from 1.5 to 2.7 mm lateral produced a nystagmus characterized by slow phases of constant velocity (around 15°/s, Table 1 ) as illustrated in Fig.  4B . These injections were mainly in the medial half of the MVN. Unlike the muscimol injections, the direction of the slow phases of the nystagmus could be ipsilateral (1 case) or contralateral (3 cases) to the side of the injection. Two injections at 4 mm, undoubtedly in the DVN (Fig. 1) , had no effect.
NMDA and APV (NMDA receptor antagonist) injections
Three 1 ml, 50 mM unilateral injections of NMDA were made at locations within 3 mm of the midline (Table 1 ). All three injections made the integrator leaky. The mean~m in was 1.1 s. The time constants exhibited a time course similar to muscimol, but with a slightly faster recovery (Fig. 3) . Four unilateral 1 ml injections of 1 mM APV were made. As can be seen in Table 1 , three of the four resulted in a leaky integrator, while the fourth produced no effect. The minimum time constant (mean 3.1 s) as well as the time course of recovery were virtually the same as in the case of injections of bicuculline (Fig. 3) . These injections ranged from the marginal zone (NPH-MVN boundary) to lateral MVN but laterality seemed not to make a difference.
Kainic acid and DNQX (kainate receptor antagonist) injections
Three 1 ml injections of 50 mM kainic acid were made within 3 mm of the midline (Table 1 ). All three injections produced a leaky integrator. The mean time constant was 0.8 s, the lowest of all averages. Three unilateral, 1 ml injections of 10 mM DNQX were made within 3 mm of the midline (Table 1) . Two out of the three injections produced a leaky integrator, while the third had no effect.
Glycine and strychnine (glycine antagonist)
Three unilateral, 1 ml injections of 1 mM glycine (one in each monkey) were made within 1.5-3 mm of the and an unstable integrator is near the medial-lateral center of the MVN at this level.
Bicuculline (GABA antagonist) injections
Nine unilateral 1 ml injections of 10 mM bicuculline midline. In each case there was no discernible effect on eye movements. Three unilateral, 1 ml injections of 100 mM strychnine were made within 1.5 -3 mm of the midline (at the locations similar to those in Fig. 1C) . No changes in eye movements were apparent after these injections. These results suggest that glycine is not a major factor in integrator connections.
Controls
In each of the three monkeys a 1 ml injection of normal saline was made within 3 mm of the midline. These produced no discernible change in eye movements.
Discussion
The main finding of this study is that injection of chemicals with either agonist or antagonist effects on GABA, glutamate, or kainate receptors in the NPH-MVN region interferes with the ability to hold the eyes steadily at an eccentric position in the orbits. Glycinergic agents had no effect. The commonest effect of pharmacological inactivation was to make the neural integrator for eye movements 'leaky', causing centripetal drifts of the eyes and gaze-evoked nystagmus. At some injection sites, either bicuculline or muscimol caused nystagmus with linear slow phases. Several of these effects have been previously reported for indiv- Table 1. idual agents (Cannon & Robinson, 1987; Cheron & Godaux, 1987; Straube et al., 1991; Mettens et al., 1994a, b) . A novel finding was that muscimol injections into the center of the MVN sometimes caused the eyes to drift away from the central position with increasingvelocity waveforms, suggesting that the neural integrator had become unstable. A similar effects has been previously reported by Straube et al. (1991) , after injection of bicuculline into the vestibular nuclei. How can these results -in which agonist or antagonist of specific transmitter receptors had similar effects -be explained?
Interpretation of the effects of pharmacological inacti6ation
Present evidence suggests that the neural integration of oculomotor signals depends on a distributed network of neurons; in the horizontal plane, the NPH-MVN region is critical (Arnold & Robinson, 1997) . Pharmacological agents may prevent the constituent neurons of this network from modulating their discharge in response to inputs from other neurons; this would cause the integrator to become leaky. This effect would be expected both for agents such as muscimol, which hyperpolarizes cells (and drives them into cutoff) and drugs such as bicuculline, which depolarize cells (and drives their discharge rates into saturation).
A suggested mechanism whereby the neural integrator could become unstable is that its constituent neurons remain functional, but that the feedback control of them -by the cerebellum -be disrupted (Kamath & Keller, 1976; Zee, Leigh & Mathieu-Millaire, 1980) . Experimentally, such instability is reported following injection of either the GABA A agonist, muscimol (this study) or the GABA A antagonist bicuculline (Straube et al., 1991) into that portion of the MVN which receives floccular afferents and lies lateral to the marginal zone (Bü ttner-Ennever, 1992) . Floccular Purkinje cells are know to be GABAergic (Mugnaini & Oertel, 1985) and so it seems possible that inactivating their projections to neurons in MVN might be responsible for instability of the neural integrator. Perhaps of relevance to this issue is that acquired nystagmus with increasing velocity waveforms is reported in patients with cerebellar lesions (Zee et al., 1980; Barton & Sharpe, 1993) .
Finally, a finding that deserves some explanation is that, after some injections with muscimol (for example, Fig. 2B ), slow phases of nystagmus appeared to show more than one time constant of drift, some appearing to be almost linear. This phenomenon has been previously documented (see, for example, Fig. 6 from the study by Straube et al., 1991) . It has been suggested (prompted by clinical observations) that centripetal drifts with more than one time constant could be due to non-linearities within the neural integrator (Abel, Dell'Osso & Daroff, 1978) ; this seems likely in the present study, since microinjections only inactivated part of the network of cells contributing to normal gaze-holding. In those cases when slow phases of nystagmus were uniformly linear (especially following bicuculline injection as in Fig. 4C ), a vestibular imbalance has been postulated (Straube et al., 1991) . 
Implications of the present study for treatment of nystagmus
Abnormal eye movements, such as pathological nystagmus, impair vision by causing excessive motion of images on the retina. Gaze-evoked nystagmus may interfere with clear vision during attempted eccentric gaze. Other disorders -such as acquired pendular nystagmus -cause ocular oscillations when the eyes are close to the central position and lead to troublesome visual symptoms. The initial reports that GABAergic projections contributed to the neural integrator (Straube et al., 1991; Mettens et al., 1994a) prompted a double-blind study to evaluate two GABAergic agents, baclofen and gabapentin (Averbuch-Heller, Tusa, Fuhry, Rottach, Ganser, Heide et al., 1997). The latter agent was shown to be an effective treatment in some patients with acquired pendular nystagmus. Another open-label study showed that memantine, a drug with glutamine-antagonist effects, was also effective in suppressing acquired pendular nystagmus (Starck, Albrecht, Straube & Dieterich, 1997) . The results of the present study strengthen the rationale for evaluating drugs that influence either GABA or glutamine mechanisms as treatment for pathological nystagmus.
